Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads

Sponsor
University of Arizona (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06018311
Collaborator
(none)
40
1
1
18
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the feasibility and effects of an adapted Exercising Together, a partnered resistance training program, on the physical and mental health of prostate cancer survivors and their informal caregiver. The Exercising Together program is designed to promote teamwork during supervised group exercise classes delivered remotely through videoconferencing software. The intervention period will be 3-months with a 3-month follow-up.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercising together
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Pilot Feasibility Study of a Culturally Adapated Partnered Strength Training Intervention for Hispanic Prostate Cancer Survivors and Their Caregivers
Anticipated Study Start Date :
Aug 30, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Feb 28, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercising Together

Dyads perform partnered exercise over 1 hour, 3 days per week in a supervised, group setting remotely for 3 months.

Behavioral: Exercising together
The Exercising Together program is a partnered functional strength training program that encourages participating dyads to interact with one another, verbally and physically, during exercise sessions. In Exercising Together, the survivor and their caregiver will build skills to work as a team. We will incorporate skills that promote and reinforce communication, motivation, and support and use this to guide training of survivor-caregiver dyads to maximize their teamwork during each exercise session. Group sessions are delivered remotely through videoconferencing software and are supervised by two trained exercise instructors. Intervention and assessment is available in English or Spanish.

Outcome Measures

Primary Outcome Measures

  1. Acceptability [3 months]

    Acceptability will be measured by adherence to the intervention calculated as the total number of classes attended divided by the total possible schedule the patient could attend using descriptive statistics.

  2. Appropriateness [3 months]

    Will be determined as the retention rate- calculated as the number of dyads completing the study versus consented using descriptive statistics.

  3. Feasibility [3 months]

    Will be determined as the enrollment rate- the number of dyads enrolled out of those approached and eligible using descriptive statistics.

  4. Implementation Success - composite measure of acceptability, appropriateness, and feasibility. [3 months]

    Implementation success is a composite measure that will be measured by a single questionnaire that will determine the extent to which the intervention is considered acceptable, appropriate, and feasible. The single questionnaire will consist of 3 measures that will be summed into one final score, The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). Responses from AIM, IAM, and FIM are summary scored with a possible range of 12-60; higher scores indicate greater acceptability, appropriateness, and feasibility.

Secondary Outcome Measures

  1. Physical activity [Physical activity will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.]

    Moderate to vigourous physical activity and sedentary time estimated using Rapid Assessment of Physical Activity (RAPA)

  2. Health-Related Quality of Life (HR-QOL) for the caregiver [HR-QOL will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.]

    Measured by the 27 item Functional Assessment of Cancer Therapy - General (FACT-G), which includes subscales on physical, social, emotional, and functional well-being. FACT-G is 27 items while FACT-P is 39 items. Response items are five-point Likert scales, where higher scores indicate higher HR-QOL.

  3. Health-Related Quality of Life (HR-QOL) for the survivor [HR-QOL will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.]

    Measured by the 39 item Functional Assessment of Cancer Therapy - Prostate (FACT-P), which includes subscales on physical, social, emotional, and functional well-being and an additional subscale specific to prostate cancer. Response items are five-point Likert scales, where higher scores indicate higher HR-QOL.physical, social, emotional, and functional well-being. FACT-G is 27 items while FACT-P is 39 items. FACT-P includes an additional subscale specific to prostate cancer. Response items are five-point likert scales, where higher scores indicate higher HR-QOL.

  4. Relationship Health [Relationship Health will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.]

    Measured by the Relationship Quality Index (RQI), a six-item assessment of communication and satisfaction on a five-point likert scale.

  5. Objective Physical Function [Objective Physical Function will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.]

    Measured by the Short Physical Performance Battery (SPPB) to determine ability to perform tasks of daily living independently. The SPPB includes 3 timed tests: 5 repeated chair stands, standing balance, and gait speed over 4 meters. The possible range of scores is 0-12.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria (Survivor only):
  1. Self-identifies as Hispanic

  2. Histologically confirmed prostate cancer diagnosis (self-report)

  3. Completed primary treatment at least 6 weeks prior at time of enrollment

  4. Has an identified caregiver in any relationship role (e.g., spouse, sibling, parent, friend) who can participate with them.

Inclusion Criteria (Caregivers):
  1. Identifies as an individual (e.g., family member or friend) who provides unpaid care or support to a participating prostate cancer survivor.
Inclusion Criteria (Survivors and Caregivers):
  1. ≥18 years of age

  2. Understands (ability to read and speak) English or Spanish and able to provide informed consent

  3. Meets the American College of Sports Medicine pre-participation screening criteria for exercise

  4. Ability to ambulate (with or without assistive devices)

  5. Willing to attend study group exercise classes online, complete remote assessments, and answer online surveys

  6. Has access to a mobile device with camera and internet.

  7. Able to participate in classes at same time as other participating member.

Exclusion Criteria:
  1. Cognitive difficulties that preclude answering the survey questions, participating in the exercise classes or performance tests, or providing informed consent as determined by the professional opinion of the Principal Investigator

  2. A medical condition, movement or neurological disorder, or medication use that contraindicates participation in moderate intensity exercise or poses a significant safety concern/risk for the well-being of the participant (e.g., declared pregnancy, poorly controlled diabetes, recent cardiac event, neuromuscular disease, untreated orthostatic hypertension, recent surgery, acute hernia, acute rheumatoid arthritis, severe memory disorders, severe balance disorder, severe hearing or vision impairment)

  3. Knowingly unable to attend >75% of the intervention classes due to conflict with the designated time of day, days of the week, and/or location for the exercise class which they initially enrolled

  4. Incapable of providing informed consent, answering survey questions, participating in the intervention, and following directions during performance testing when English or Spanish language is used

  5. Unable to be in the same location with participating member during remote exercise classes and performance testing and/or insufficient internet connectivity to support required videoconferencing software

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Arizona Cancer Center Tucson Arizona United States 85719

Sponsors and Collaborators

  • University of Arizona

Investigators

  • Principal Investigator: Meghan B Skiba, PhD, MS, MPH, RDN, University of Arizona College of Nursing Biobehavioral Health Science Division

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Arizona
ClinicalTrials.gov Identifier:
NCT06018311
Other Study ID Numbers:
  • STUDY00003138
First Posted:
Aug 30, 2023
Last Update Posted:
Sep 1, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Arizona
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2023